ArticleJournal of the Turkish German Gynecological Association2026
Maternal and neonatal outcomes following cesarean myomectomy: a comparison between fibroid-associated and fibroid-free cesarean deliveries.
Article in Journal of the Turkish German Gynecological Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To compare maternal and neonatal outcomes among women undergoing cesarean section (CS) with concomitant myomectomy, women with uterine fibroids managed conservatively at cesarean delivery, and women without uterine fibroids. Material and Methods: This retrospective cohort study included women who delivered by CS between May 2017 and December 2024. Patients were classified into three groups: CS with myomectomy (Group 1), CS with fibroids without myomectomy (Group 2), and CS without fibroids (Group 3). Maternal outcomes included perioperative changes in hemoglobin, hematocrit, and platelet counts, transfusion requirement, and length of hospital stay. Neonatal outcomes included birth weight, birth length, and Apgar scores. Appropriate parametric and non-parametric statistical tests were used for group comparisons. Results: The study cohort numbered 682 with 252 (36.95%), 178 (26.1%) and 252 (36.95%) women in Groups 1, 2 and 3, respectively. Postoperative hemoglobin, hematocrit, and platelet levels differed significantly among the three groups (all p<0.05). However, hemoglobin deficit did not differ significantly between Group 1 and Group 2 (p=0.346), while both groups showed greater hemoglobin deficit than Group 3 (p<0.05). Transfusion rates and hospitalization duration differed significantly between groups (p<0.05), with longer hospital stay observed in transfused patients regardless of group. Maximum myoma volume was higher in Group 1, whereas myoma count was greater in Group 2 and total myoma volume was comparable between these groups (p=0.09). Neonatal birth weight was significantly lower in Group 2 compared with Groups 1 and 3 (p<0.05), while no difference was observed between Groups 1 and 3 (p=0.956). Other neonatal outcomes were similar. Conclusion: Cesarean myomectomy was associated with larger changes in hematologic parameters and transfusion rates; however, hemoglobin deficit appears related to fibroid presence rather than myomectomy itself. Neonatal outcomes were not adversely affected by cesarean myomectomy, whereas untreated fibroids appeared to be associated with lower birth weight.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.